<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00706264</url>
  </required_header>
  <id_info>
    <org_study_id>PECEP-TRIAL</org_study_id>
    <nct_id>NCT00706264</nct_id>
  </id_info>
  <brief_title>Prevention of Preterm Birth Using Cervical Pessary in Pregnant Women With Short Cervix</brief_title>
  <acronym>PECEP</acronym>
  <official_title>Randomized Controlled Trial: Prevention of Preterm Birth Using Cervical Pessary in Pregnant Women With Short Cervix (PECEP)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maternal-Infantil Vall d´Hebron Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hospital Universitario de Canarias</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Son Llatzer</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Institut Universitari Dexeus</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Maternal-Infantil Vall d´Hebron Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Placement of a vaginal pessary reduces significantly the rate of spontaneous preterm birth in&#xD;
      pregnant women with short cervical length at 18-22 weeks scan.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This trial includes pregnant women undergoing routine ultrasound examination at 18.0 to 22.6&#xD;
      weeks of gestation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2007</start_date>
  <completion_date type="Actual">July 2014</completion_date>
  <primary_completion_date type="Actual">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Spontaneous Delivery Before 34 Completed Weeks</measure>
    <time_frame>Between 24 and 34 weeks</time_frame>
    <description>Number of spontaneous preterm births before 34 weeks occurred in each group.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Birthweight Less Than 1500 g</measure>
    <time_frame>Time of delivery</time_frame>
    <description>Number of newborns whose birthweight is less than 1500 grams</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Birthweight Less Than 2500 g</measure>
    <time_frame>Time of delivery</time_frame>
    <description>Number of newborns whose birthweight is less than 2500 grams</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intrauterine Fetal Demise</measure>
    <time_frame>Pregnancy</time_frame>
    <description>The number of fetal deaths in the pessary group was compared to those in the no pessary group</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neonatal Death</measure>
    <time_frame>Between birth and 28 days of age</time_frame>
    <description>The number of neonatal deaths in the pessary group was compared to those in the no pessary group</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraventricular Haemorrhage</measure>
    <time_frame>Between birth and 28 days of age</time_frame>
    <description>The number of neonatal intraventricular haemorrhage in the pessary group was compared to those in the no pessary group</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory Distress Syndrome</measure>
    <time_frame>Between birth and 28 days of age</time_frame>
    <description>The number of neonatal Respiratory distress syndrome in the pessary group was compared to those in the no pessary group</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Retinopathy of Prematurity</measure>
    <time_frame>Between birth and 28 days of age</time_frame>
    <description>The number of neonatal retinopathy in the pessary group was compared to those in the no pessary group</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Necrotising Enterocolitis</measure>
    <time_frame>Between birth and 28 days of age</time_frame>
    <description>The number of neonatal necrotising enterocolitis in the pessary group was compared to those in the no pessary group</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment for Sepsis</measure>
    <time_frame>Between birth and 28 days of age</time_frame>
    <description>The number of neonatal cases of treatment needed for sepsis in the pessary group was compared to those in the no pessary group</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composite Adverse Outcomes</measure>
    <time_frame>Between birth and 28 days of age</time_frame>
    <description>The number of neonatal cases with composite adverse outcomes in the pessary group was compared to those in the no pessary group</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Spontaneous Delivery Before 28 Completed Weeks</measure>
    <time_frame>Between 24 and 28 weeks</time_frame>
    <description>Number of preterm births before 28 weeks occurred in each group.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Any Delivery Before 34 Completed Weeks</measure>
    <time_frame>Between 24 and 34 weeks</time_frame>
    <description>Number of all preterm births before 34 weeks occurred in each group.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Spontaneous Delivery Before 37 Completed Weeks</measure>
    <time_frame>Between 24 and 37 weeks</time_frame>
    <description>Number of preterm births before 37 weeks occurred in each group.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gestational Age at Delivery</measure>
    <time_frame>At time of birth</time_frame>
    <description>Number of weeks of gestation completed by time of delivery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of Tocolysis</measure>
    <time_frame>participants will be followed for the duration of pregnancy, up to nine months</time_frame>
    <description>Number of participants required use of tocolytic medication</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of Antenatal Steroids</measure>
    <time_frame>participants will be followed for the duration of pregnancy, up to nine months</time_frame>
    <description>Number of participants that received betamethasone to reduce morbidity of expected preterm delivery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Chorioamnionitis</measure>
    <time_frame>participants will be followed for the duration of pregnancy, up to nine months</time_frame>
    <description>Number of participants that showed intrauterine infection diagnosed by maternal tachycardia, fever, uterine tenderness, purulent or abnormal cervical discharge, fetal tachycardia.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vaginal Bleeding</measure>
    <time_frame>participants will be followed for the duration of pregnancy, up to nine months</time_frame>
    <description>Number of participants who experienced bleeding from lower genital tract during antepartum period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Preterm Premature Rupture of Membranes</measure>
    <time_frame>participants will be followed for the duration of pregnancy, up to nine months</time_frame>
    <description>Number of participants who experienced rupture of membranes as diagnosed by speculum exam showing pooling, ferning, positive nitrazine test, positive amnisure test.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cesarean Delivery</measure>
    <time_frame>At time of delivery</time_frame>
    <description>Number of participants that underwent cesarean delivery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vaginal Discharge</measure>
    <time_frame>participants will be followed for the duration of pregnancy, up to nine months</time_frame>
    <description>Number of participants who experienced an increased vaginal discharge.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pessary Repositioning Without Removal</measure>
    <time_frame>participants will be followed for the duration of pregnancy, up to nine months</time_frame>
    <description>Number of participants who required pessary repositioning without removal. This outcome measure only applied to the Experimental (Pessary Arm) and no data were collected from participants in the No Intervention _(No Pessary Arm).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pessary Withdrawal</measure>
    <time_frame>participants will be followed for the duration of pregnancy, up to nine months</time_frame>
    <description>Number of participants who experience pessary withdrawal. This outcome measure only applied to the Experimental (Pessary Arm) and no data were collected from participants in the No Intervention _(No Pessary Arm).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">385</enrollment>
  <condition>Preterm Birth</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Expectant management</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Placement of arabin pessary since 23 weeks until 37 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Silicon ring (Arabin Pessary)</intervention_name>
    <description>Placement of a silicon pessary in the vagina, around the cervix.</description>
    <arm_group_label>2</arm_group_label>
    <other_name>Vaginal pessaries CE 0482 MED / CERT ISO 9003 /EN 46003</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Singleton pregnancy&#xD;
&#xD;
          -  Minimal age of 18 years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Major fetal abnormalities (requiring surgery or leading to infant death or severe&#xD;
             handicap)&#xD;
&#xD;
          -  SROM at the time of randomization&#xD;
&#xD;
          -  Cervical cerclage in situ&#xD;
&#xD;
          -  Active vaginal bleeding&#xD;
&#xD;
          -  Previous cone biopsy or cerclage&#xD;
&#xD;
          -  Major uterine structural anomalies&#xD;
&#xD;
          -  Placenta previa&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>ELENA CARRERAS, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Maternal-Infantil Vall d´Hebron Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Materno-Infantil de Canarias</name>
      <address>
        <city>Las Palmas de Gran Canaria</city>
        <state>Gran Canaria</state>
        <zip>35016</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Son Llàtzer</name>
      <address>
        <city>Palma de Mallorca</city>
        <state>Mallorca</state>
        <zip>07198</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de Reus</name>
      <address>
        <city>Reus</city>
        <state>Tarragona</state>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Vall d´Hebron</name>
      <address>
        <city>Barcelona</city>
        <zip>08035</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institut Universitary Dexeus</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de Fuenlabrada</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>June 24, 2008</study_first_submitted>
  <study_first_submitted_qc>June 26, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 27, 2008</study_first_posted>
  <results_first_submitted>February 11, 2018</results_first_submitted>
  <results_first_submitted_qc>March 16, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">March 17, 2021</results_first_posted>
  <last_update_submitted>March 16, 2021</last_update_submitted>
  <last_update_submitted_qc>March 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Maternal-Infantil Vall d´Hebron Hospital</investigator_affiliation>
    <investigator_full_name>Maria Goya, MD, PhD</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <keyword>Short cervix</keyword>
  <keyword>preterm birth</keyword>
  <keyword>arabin pessary</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Premature Birth</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Silicon</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>You are right that our fi rst planned sample size was 2780 patients. However, after the first interim analysis, and in accordance with the advice of our Data Monitoring Committee, the protocol was amended to reach the new and fi nal sample size.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Expectant Management</title>
          <description>Expectant management: Current conventional management.</description>
        </group>
        <group group_id="P2">
          <title>Placement of Arabin Pessary Since 23 Weeks Until 37 Weeks</title>
          <description>Placement of arabin pessary since 23 weeks until 37 weeks&#xD;
Silicon ring (Arabin Pessary): Placement of a silicon pessary in the vagina, around the cervix.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="193"/>
                <participants group_id="P2" count="192"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="190"/>
                <participants group_id="P2" count="190"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Expectant Management</title>
          <description>Both groups were seen by the clinical team of the trial at each centre every month until delivery. Transabdominal ultrasonography was done for fetal biometries and wellbeing, clinical questionnaire was administered for confi rmation of correct device placement in the pessary group (fi gure 2), vaginal swab was taken for study of bacteriological infection, and transvaginal ultra sonography was done to measure cervical length (fi gure 3)</description>
        </group>
        <group group_id="B2">
          <title>Placement of Arabin Pessary Since 23 Weeks Until 37 Weeks</title>
          <description>The pessary was removed during the 37th week of gestation. Indications for pessary removal before this time were active vaginal bleeding, risk of preterm labour with persistent contractions despite tocolysis, or severe patient discomfort.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="190"/>
            <count group_id="B2" value="190"/>
            <count group_id="B3" value="380"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="190"/>
                    <measurement group_id="B2" value="190"/>
                    <measurement group_id="B3" value="380"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29.6" spread="5.4"/>
                    <measurement group_id="B2" value="30.3" spread="5.1"/>
                    <measurement group_id="B3" value="30.1" spread="5.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="190"/>
                    <measurement group_id="B2" value="190"/>
                    <measurement group_id="B3" value="380"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="56"/>
                    <measurement group_id="B2" value="58"/>
                    <measurement group_id="B3" value="114"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="134"/>
                    <measurement group_id="B2" value="132"/>
                    <measurement group_id="B3" value="266"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Spain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="190"/>
                    <measurement group_id="B2" value="190"/>
                    <measurement group_id="B3" value="380"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Spontaneous Delivery Before 34 Completed Weeks</title>
        <description>Number of spontaneous preterm births before 34 weeks occurred in each group.</description>
        <time_frame>Between 24 and 34 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>No Intervention: No Pessary</title>
            <description>No pessary will be used. Subjects will receive standard obstetrical care and management.</description>
          </group>
          <group group_id="O2">
            <title>Experimental: Pessary</title>
            <description>Use of Arabin pessary. Pessary placed around the cervix between 20 and 23 weeks gestation, and will be removed during the 37th week of pregnancy.</description>
          </group>
        </group_list>
        <measure>
          <title>Spontaneous Delivery Before 34 Completed Weeks</title>
          <description>Number of spontaneous preterm births before 34 weeks occurred in each group.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="190"/>
                <count group_id="O2" value="190"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51"/>
                    <measurement group_id="O2" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Birthweight Less Than 1500 g</title>
        <description>Number of newborns whose birthweight is less than 1500 grams</description>
        <time_frame>Time of delivery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>No Intervention: No Pessary</title>
            <description>No pessary will be used. Subjects will receive standard obstetrical care and management.</description>
          </group>
          <group group_id="O2">
            <title>Experimental: Pessary</title>
            <description>Use of Arabin pessary. Pessary placed around the cervix between 20 and 23 weeks gestation, and will be removed during the 37th week of pregnancy.</description>
          </group>
        </group_list>
        <measure>
          <title>Birthweight Less Than 1500 g</title>
          <description>Number of newborns whose birthweight is less than 1500 grams</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="190"/>
                <count group_id="O2" value="190"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26"/>
                    <measurement group_id="O2" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Birthweight Less Than 2500 g</title>
        <description>Number of newborns whose birthweight is less than 2500 grams</description>
        <time_frame>Time of delivery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Expectant Management</title>
            <description>Expectant management: usual management</description>
          </group>
          <group group_id="O2">
            <title>Placement of Arabin Pessary Since 23 Weeks Until 37 Weeks</title>
            <description>Silicon ring (Arabin Pessary): Placement of a silicon pessary in the vagina, around the cervix.</description>
          </group>
        </group_list>
        <measure>
          <title>Birthweight Less Than 2500 g</title>
          <description>Number of newborns whose birthweight is less than 2500 grams</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="190"/>
                <count group_id="O2" value="190"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="56"/>
                    <measurement group_id="O2" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Intrauterine Fetal Demise</title>
        <description>The number of fetal deaths in the pessary group was compared to those in the no pessary group</description>
        <time_frame>Pregnancy</time_frame>
        <group_list>
          <group group_id="O1">
            <title>No Intervention: No Pessary</title>
            <description>No pessary will be used. Subjects will receive standard obstetrical care and management.</description>
          </group>
          <group group_id="O2">
            <title>Experimental: Pessary</title>
            <description>Use of Arabin pessary. Pessary placed around the cervix between 20 and 23 weeks gestation, and will be removed during the 37th week of pregnancy.</description>
          </group>
        </group_list>
        <measure>
          <title>Intrauterine Fetal Demise</title>
          <description>The number of fetal deaths in the pessary group was compared to those in the no pessary group</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="190"/>
                <count group_id="O2" value="190"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Neonatal Death</title>
        <description>The number of neonatal deaths in the pessary group was compared to those in the no pessary group</description>
        <time_frame>Between birth and 28 days of age</time_frame>
        <group_list>
          <group group_id="O1">
            <title>No Intervention: No Pessary</title>
            <description>No pessary will be used. Subjects will receive standard obstetrical care and management.</description>
          </group>
          <group group_id="O2">
            <title>Experimental: Pessary</title>
            <description>Use of Arabin pessary. Pessary placed around the cervix between 20 and 23 weeks gestation, and will be removed during the 37th week of pregnancy.</description>
          </group>
        </group_list>
        <measure>
          <title>Neonatal Death</title>
          <description>The number of neonatal deaths in the pessary group was compared to those in the no pessary group</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="190"/>
                <count group_id="O2" value="190"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Intraventricular Haemorrhage</title>
        <description>The number of neonatal intraventricular haemorrhage in the pessary group was compared to those in the no pessary group</description>
        <time_frame>Between birth and 28 days of age</time_frame>
        <group_list>
          <group group_id="O1">
            <title>No Intervention: No Pessary</title>
            <description>No pessary will be used. Subjects will receive standard obstetrical care and management.</description>
          </group>
          <group group_id="O2">
            <title>Experimental: Pessary</title>
            <description>Use of Arabin pessary. Pessary placed around the cervix between 20 and 23 weeks gestation, and will be removed during the 37th week of pregnancy.</description>
          </group>
        </group_list>
        <measure>
          <title>Intraventricular Haemorrhage</title>
          <description>The number of neonatal intraventricular haemorrhage in the pessary group was compared to those in the no pessary group</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="190"/>
                <count group_id="O2" value="190"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Respiratory Distress Syndrome</title>
        <description>The number of neonatal Respiratory distress syndrome in the pessary group was compared to those in the no pessary group</description>
        <time_frame>Between birth and 28 days of age</time_frame>
        <group_list>
          <group group_id="O1">
            <title>No Intervention: No Pessary</title>
            <description>No pessary will be used. Subjects will receive standard obstetrical care and management.</description>
          </group>
          <group group_id="O2">
            <title>Experimental: Pessary</title>
            <description>Use of Arabin pessary. Pessary placed around the cervix between 20 and 23 weeks gestation, and will be removed during the 37th week of pregnancy.</description>
          </group>
        </group_list>
        <measure>
          <title>Respiratory Distress Syndrome</title>
          <description>The number of neonatal Respiratory distress syndrome in the pessary group was compared to those in the no pessary group</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="190"/>
                <count group_id="O2" value="190"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Retinopathy of Prematurity</title>
        <description>The number of neonatal retinopathy in the pessary group was compared to those in the no pessary group</description>
        <time_frame>Between birth and 28 days of age</time_frame>
        <group_list>
          <group group_id="O1">
            <title>No Intervention: No Pessary</title>
            <description>No pessary will be used. Subjects will receive standard obstetrical care and management.</description>
          </group>
          <group group_id="O2">
            <title>Experimental: Pessary</title>
            <description>Use of Arabin pessary. Pessary placed around the cervix between 20 and 23 weeks gestation, and will be removed during the 37th week of pregnancy.</description>
          </group>
        </group_list>
        <measure>
          <title>Retinopathy of Prematurity</title>
          <description>The number of neonatal retinopathy in the pessary group was compared to those in the no pessary group</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="190"/>
                <count group_id="O2" value="190"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Necrotising Enterocolitis</title>
        <description>The number of neonatal necrotising enterocolitis in the pessary group was compared to those in the no pessary group</description>
        <time_frame>Between birth and 28 days of age</time_frame>
        <group_list>
          <group group_id="O1">
            <title>No Intervention: No Pessary</title>
            <description>No pessary will be used. Subjects will receive standard obstetrical care and management.</description>
          </group>
          <group group_id="O2">
            <title>Experimental: Pessary</title>
            <description>Use of Arabin pessary. Pessary placed around the cervix between 20 and 23 weeks gestation, and will be removed during the 37th week of pregnancy.</description>
          </group>
        </group_list>
        <measure>
          <title>Necrotising Enterocolitis</title>
          <description>The number of neonatal necrotising enterocolitis in the pessary group was compared to those in the no pessary group</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="190"/>
                <count group_id="O2" value="190"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Treatment for Sepsis</title>
        <description>The number of neonatal cases of treatment needed for sepsis in the pessary group was compared to those in the no pessary group</description>
        <time_frame>Between birth and 28 days of age</time_frame>
        <group_list>
          <group group_id="O1">
            <title>No Intervention: No Pessary</title>
            <description>No pessary will be used. Subjects will receive standard obstetrical care and management.</description>
          </group>
          <group group_id="O2">
            <title>Experimental: Pessary</title>
            <description>Use of Arabin pessary. Pessary placed around the cervix between 20 and 23 weeks gestation, and will be removed during the 37th week of pregnancy.</description>
          </group>
        </group_list>
        <measure>
          <title>Treatment for Sepsis</title>
          <description>The number of neonatal cases of treatment needed for sepsis in the pessary group was compared to those in the no pessary group</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="190"/>
                <count group_id="O2" value="190"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Composite Adverse Outcomes</title>
        <description>The number of neonatal cases with composite adverse outcomes in the pessary group was compared to those in the no pessary group</description>
        <time_frame>Between birth and 28 days of age</time_frame>
        <group_list>
          <group group_id="O1">
            <title>No Intervention: No Pessary</title>
            <description>No pessary will be used. Subjects will receive standard obstetrical care and management.</description>
          </group>
          <group group_id="O2">
            <title>Experimental: Pessary</title>
            <description>Use of Arabin pessary. Pessary placed around the cervix between 20 and 23 weeks gestation, and will be removed during the 37th week of pregnancy.</description>
          </group>
        </group_list>
        <measure>
          <title>Composite Adverse Outcomes</title>
          <description>The number of neonatal cases with composite adverse outcomes in the pessary group was compared to those in the no pessary group</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="190"/>
                <count group_id="O2" value="190"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Spontaneous Delivery Before 28 Completed Weeks</title>
        <description>Number of preterm births before 28 weeks occurred in each group.</description>
        <time_frame>Between 24 and 28 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>No Intervention: No Pessary</title>
            <description>No pessary will be used. Subjects will receive standard obstetrical care and management.</description>
          </group>
          <group group_id="O2">
            <title>Experimental: Pessary</title>
            <description>Use of Arabin pessary. Pessary placed around the cervix between 20 and 23 weeks gestation, and will be removed during the 37th week of pregnancy.</description>
          </group>
        </group_list>
        <measure>
          <title>Spontaneous Delivery Before 28 Completed Weeks</title>
          <description>Number of preterm births before 28 weeks occurred in each group.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="190"/>
                <count group_id="O2" value="190"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Any Delivery Before 34 Completed Weeks</title>
        <description>Number of all preterm births before 34 weeks occurred in each group.</description>
        <time_frame>Between 24 and 34 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>No Intervention: No Pessary</title>
            <description>No pessary will be used. Subjects will receive standard obstetrical care and management.</description>
          </group>
          <group group_id="O2">
            <title>Experimental: Pessary</title>
            <description>Use of Arabin pessary. Pessary placed around the cervix between 20 and 23 weeks gestation, and will be removed during the 37th week of pregnancy.</description>
          </group>
        </group_list>
        <measure>
          <title>Any Delivery Before 34 Completed Weeks</title>
          <description>Number of all preterm births before 34 weeks occurred in each group.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="190"/>
                <count group_id="O2" value="190"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53"/>
                    <measurement group_id="O2" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Spontaneous Delivery Before 37 Completed Weeks</title>
        <description>Number of preterm births before 37 weeks occurred in each group.</description>
        <time_frame>Between 24 and 37 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>No Intervention: No Pessary</title>
            <description>No pessary will be used. Subjects will receive standard obstetrical care and management.</description>
          </group>
          <group group_id="O2">
            <title>Experimental: Pessary</title>
            <description>Use of Arabin pessary. Pessary placed around the cervix between 20 and 23 weeks gestation, and will be removed during the 37th week of pregnancy.</description>
          </group>
        </group_list>
        <measure>
          <title>Spontaneous Delivery Before 37 Completed Weeks</title>
          <description>Number of preterm births before 37 weeks occurred in each group.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="190"/>
                <count group_id="O2" value="190"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="113"/>
                    <measurement group_id="O2" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Gestational Age at Delivery</title>
        <description>Number of weeks of gestation completed by time of delivery</description>
        <time_frame>At time of birth</time_frame>
        <group_list>
          <group group_id="O1">
            <title>No Intervention: No Pessary</title>
            <description>No pessary will be used. Subjects will receive standard obstetrical care and management.</description>
          </group>
          <group group_id="O2">
            <title>Experimental: Pessary</title>
            <description>Use of Arabin pessary. Pessary placed around the cervix between 20 and 23 weeks gestation, and will be removed during the 37th week of pregnancy.</description>
          </group>
        </group_list>
        <measure>
          <title>Gestational Age at Delivery</title>
          <description>Number of weeks of gestation completed by time of delivery</description>
          <units>weeks</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="190"/>
                <count group_id="O2" value="190"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34.9" spread="4.0"/>
                    <measurement group_id="O2" value="37.7" spread="2.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Use of Tocolysis</title>
        <description>Number of participants required use of tocolytic medication</description>
        <time_frame>participants will be followed for the duration of pregnancy, up to nine months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>No Intervention: No Pessary</title>
            <description>No pessary will be used. Subjects will receive standard obstetrical care and management.</description>
          </group>
          <group group_id="O2">
            <title>Experimental: Pessary</title>
            <description>Use of Arabin pessary. Pessary placed around the cervix between 20 and 23 weeks gestation, and will be removed during the 37th week of pregnancy.</description>
          </group>
        </group_list>
        <measure>
          <title>Use of Tocolysis</title>
          <description>Number of participants required use of tocolytic medication</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="190"/>
                <count group_id="O2" value="190"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="101"/>
                    <measurement group_id="O2" value="64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Use of Antenatal Steroids</title>
        <description>Number of participants that received betamethasone to reduce morbidity of expected preterm delivery</description>
        <time_frame>participants will be followed for the duration of pregnancy, up to nine months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>No Intervention: No Pessary</title>
            <description>No pessary will be used. Subjects will receive standard obstetrical care and management.</description>
          </group>
          <group group_id="O2">
            <title>Experimental: Pessary</title>
            <description>Use of Arabin pessary. Pessary placed around the cervix between 20 and 23 weeks gestation, and will be removed during the 37th week of pregnancy.</description>
          </group>
        </group_list>
        <measure>
          <title>Use of Antenatal Steroids</title>
          <description>Number of participants that received betamethasone to reduce morbidity of expected preterm delivery</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="190"/>
                <count group_id="O2" value="190"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="121"/>
                    <measurement group_id="O2" value="80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Chorioamnionitis</title>
        <description>Number of participants that showed intrauterine infection diagnosed by maternal tachycardia, fever, uterine tenderness, purulent or abnormal cervical discharge, fetal tachycardia.</description>
        <time_frame>participants will be followed for the duration of pregnancy, up to nine months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>No Intervention: No Pessary</title>
            <description>No pessary will be used. Subjects will receive standard obstetrical care and management.</description>
          </group>
          <group group_id="O2">
            <title>Experimental: Pessary</title>
            <description>Use of Arabin pessary. Pessary placed around the cervix between 20 and 23 weeks gestation, and will be removed during the 37th week of pregnancy.</description>
          </group>
        </group_list>
        <measure>
          <title>Chorioamnionitis</title>
          <description>Number of participants that showed intrauterine infection diagnosed by maternal tachycardia, fever, uterine tenderness, purulent or abnormal cervical discharge, fetal tachycardia.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="190"/>
                <count group_id="O2" value="190"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Vaginal Bleeding</title>
        <description>Number of participants who experienced bleeding from lower genital tract during antepartum period</description>
        <time_frame>participants will be followed for the duration of pregnancy, up to nine months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>No Intervention: No Pessary</title>
            <description>No pessary will be used. Subjects will receive standard obstetrical care and management.</description>
          </group>
          <group group_id="O2">
            <title>Experimental: Pessary</title>
            <description>Use of Arabin pessary. Pessary placed around the cervix between 20 and 23 weeks gestation, and will be removed during the 37th week of pregnancy.</description>
          </group>
        </group_list>
        <measure>
          <title>Vaginal Bleeding</title>
          <description>Number of participants who experienced bleeding from lower genital tract during antepartum period</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="190"/>
                <count group_id="O2" value="190"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Preterm Premature Rupture of Membranes</title>
        <description>Number of participants who experienced rupture of membranes as diagnosed by speculum exam showing pooling, ferning, positive nitrazine test, positive amnisure test.</description>
        <time_frame>participants will be followed for the duration of pregnancy, up to nine months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>No Intervention: No Pessary</title>
            <description>No pessary will be used. Subjects will receive standard obstetrical care and management.</description>
          </group>
          <group group_id="O2">
            <title>Experimental: Pessary</title>
            <description>Use of Arabin pessary. Pessary placed around the cervix between 20 and 23 weeks gestation, and will be removed during the 37th week of pregnancy.</description>
          </group>
        </group_list>
        <measure>
          <title>Preterm Premature Rupture of Membranes</title>
          <description>Number of participants who experienced rupture of membranes as diagnosed by speculum exam showing pooling, ferning, positive nitrazine test, positive amnisure test.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="190"/>
                <count group_id="O2" value="190"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cesarean Delivery</title>
        <description>Number of participants that underwent cesarean delivery</description>
        <time_frame>At time of delivery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>No Intervention: No Pessary</title>
            <description>No pessary will be used. Subjects will receive standard obstetrical care and management.</description>
          </group>
          <group group_id="O2">
            <title>Experimental: Pessary</title>
            <description>Use of Arabin pessary. Pessary placed around the cervix between 20 and 23 weeks gestation, and will be removed during the 37th week of pregnancy.</description>
          </group>
        </group_list>
        <measure>
          <title>Cesarean Delivery</title>
          <description>Number of participants that underwent cesarean delivery</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="190"/>
                <count group_id="O2" value="190"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40"/>
                    <measurement group_id="O2" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Vaginal Discharge</title>
        <description>Number of participants who experienced an increased vaginal discharge.</description>
        <time_frame>participants will be followed for the duration of pregnancy, up to nine months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>No Intervention: No Pessary</title>
            <description>No pessary will be used. Subjects will receive standard obstetrical care and management.</description>
          </group>
          <group group_id="O2">
            <title>Experimental: Pessary</title>
            <description>Use of Arabin pessary. Pessary placed around the cervix between 20 and 23 weeks gestation, and will be removed during the 37th week of pregnancy.</description>
          </group>
        </group_list>
        <measure>
          <title>Vaginal Discharge</title>
          <description>Number of participants who experienced an increased vaginal discharge.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="190"/>
                <count group_id="O2" value="190"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87"/>
                    <measurement group_id="O2" value="190"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pessary Repositioning Without Removal</title>
        <description>Number of participants who required pessary repositioning without removal. This outcome measure only applied to the Experimental (Pessary Arm) and no data were collected from participants in the No Intervention _(No Pessary Arm).</description>
        <time_frame>participants will be followed for the duration of pregnancy, up to nine months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>No Intervention: No Pessary</title>
            <description>No pessary will be used. Subjects will receive standard obstetrical care and management.</description>
          </group>
          <group group_id="O2">
            <title>Experimental: Pessary</title>
            <description>Use of Arabin pessary. Pessary placed around the cervix between 20 and 23 weeks gestation, and will be removed during the 37th week of pregnancy.</description>
          </group>
        </group_list>
        <measure>
          <title>Pessary Repositioning Without Removal</title>
          <description>Number of participants who required pessary repositioning without removal. This outcome measure only applied to the Experimental (Pessary Arm) and no data were collected from participants in the No Intervention _(No Pessary Arm).</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="190"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pessary Withdrawal</title>
        <description>Number of participants who experience pessary withdrawal. This outcome measure only applied to the Experimental (Pessary Arm) and no data were collected from participants in the No Intervention _(No Pessary Arm).</description>
        <time_frame>participants will be followed for the duration of pregnancy, up to nine months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>No Intervention: No Pessary</title>
            <description>No pessary will be used. Subjects will receive standard obstetrical care and management.</description>
          </group>
          <group group_id="O2">
            <title>Experimental: Pessary</title>
            <description>Use of Arabin pessary. Pessary placed around the cervix between 20 and 23 weeks gestation, and will be removed during the 37th week of pregnancy.</description>
          </group>
        </group_list>
        <measure>
          <title>Pessary Withdrawal</title>
          <description>Number of participants who experience pessary withdrawal. This outcome measure only applied to the Experimental (Pessary Arm) and no data were collected from participants in the No Intervention _(No Pessary Arm).</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="190"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Starting at 24 weeks until 28 days after birth</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Expectant Management</title>
          <description>Expectant management: usual management</description>
        </group>
        <group group_id="E2">
          <title>Placement of Arabin Pessary Since 23 Weeks Until 37 Weeks</title>
          <description>Silicon ring (Arabin Pessary): Placement of a silicon pessary in the vagina, around the cervix.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="190"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="190"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="190"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="190"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="190"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="190"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Maria M Goya</name_or_title>
      <organization>Hospital Vall d'Hebron</organization>
      <phone>934893085 ext 4652</phone>
      <email>maria.goya@vhir.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

